Latest / Oncology Data Advisor
Targeting p53 in the Treatment of Hematologic Malignancies With Matthew Davids, MD, MMSc
Tumor suppressor gene p53 is the most frequently mutated gene in human malignancy. Through a complex series of molecular events, p53 leads to malignant cell proliferation and plays a significant role in tumor formation. In this interview with Oncology Data Advisor, Dr. Matthew Davids of Harvard Medical School delves further into the latest research in p53-directed therapeutic strategies and the future of targeting this specific mutation.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.